$ECL

Kirkland Scott D sold $930K of ECL

Kirkland Scott D (CHIEF FINANCIAL OFFICER) sold 3,357 shares of ECOLAB INC. (ECL) at $276.96 ($0.93M total) on 2026-07-30.

Original reporting
SEC EDGAR · Kirkland Scott D
Published Jul 31, 2026, 8:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 8:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ECL
Neutral
medium confidence
Mentioned
$ECL
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ECLNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings. It does not include any company performance or forward-looking guidance.

02

Market read

Traders may note insider selling as a minor sentiment datapoint, but there is no fundamental update to trade on.

03

What to watch

Insider sales are more informative when paired with other signals (buying by insiders, guidance changes, material events). This filing contains no such accompanying catalysts.

Relevance 5/10Novelty 3/10Timing: filed 2026-07-31 after-hours; sale executed 2026-07-30

Background

The article is an SEC Form 4 insider transaction disclosure for Ecolab, reported by the CFO.

Company-level read

Ticker impact

$ECLNeutralMedium confidence
Context

Ecolab CFO Kirkland Scott D sold 3,357 shares at $276.96 on 2026-07-30, totaling $929,754.72, per Form 4.

Expected impact

Likely minimal near-term impact; any effect is more about sentiment than new fundamentals.

Evidence & confidence

Form 4 insider sales are common and often non-informational; the filing provides transaction details but no earnings, guidance, or operational change.

Market effects

No direct read-through to industrial chemicals or consumer hygiene peers from a single CFO sale.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan does not necessarily imply negative information; sales can be driven by diversification, taxes, or pre-existing personal liquidity needs.

Key entities

  • Ecolab Inc.

    Subject of the Form 4 insider sale disclosure.

  • Kirkland Scott D

    Ecolab CFO who reported the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ECLMedAI 8/10

Ecolab Inc (ECL) (Q3 2026) Earnings Call Highlights: 7% Organic Sales Growth, 63%

Ecolab Inc (ECL) reported 7% organic sales growth in Q3 2026, with High-Tech segment growing 63%. Challenges include North American restaurant traffic decline, commodity cost inflation, and a 1% growth headwind from the Middle East. CoolIT acquisition is expected to impact EPS. CEO Christophe Beck reaffirmed 2027 margin targets and growth expectations, citing strong demand in High-Tech and Life Sciences.

$ECLMed

Ecolab (ECL) Q3 2026 Earnings Call Transcript

Ecolab (ECL) reported Q3 2026 pro forma sales growth of high single digits and adjusted EPS growth of mid-teens. The company highlighted strong performance in Food & Beverage, Life Sciences, and Global High-Tech, with organic sales growth of 8%, 17%, and 63% respectively. Ecolab also emphasized its One Ecolab model, which integrates water, hygiene, and digital solutions to drive customer value and growth. The company plans to expand field sales and service offerings to accelerate growth further.

$ECLMedAI 8/10

Ecolab Q3 Earnings Call Highlights

Ecolab (ECL) reported Q3 growth in Life Sciences (17%), Ecolab Digital (34%), and Pest Elimination (8%). Global High-Tech saw 63% growth, driven by data-center cooling and water systems. Ecolab expects 2027 organic sales growth at the upper end of its 5%-7% target range and adjusted operating-income margin of 20%. The company is integrating recent acquisitions and reducing leverage.

$ECLHighAI 8/10

Ecolab Q3 2026 slides: organic growth accelerates to 7%, margins expand

Ecolab (ECL) reported Q3 2026 results with 7% organic sales growth, 13% total sales growth, and adjusted EPS of $2.18, slightly above estimates. Revenue was $4.69B, below consensus. Stock rose 1.29% premarket. High-growth segments like Global High-Tech and Life Sciences drove performance. Management expects full-year EPS of $8.10-$8.20 and 2027 margin target of 20%.

$ECLMedAI 8/10

Ecolab Q3 Earnings In-Line With Estimates, Revenues Increase Y/Y

Ecolab reported Q3 2026 adjusted earnings of $2.18 per share, up 5% Y/Y, matching estimates. Revenues rose 13% to $4.69B, beating estimates. Organic sales increased 7%, with strong demand in Global High-Tech and Life Sciences. ECL raised its 2026 adjusted earnings outlook to $8.10-$8.20 per share, citing acquisitions and pricing gains.